Combined biofeedback and vestibular rehabilitation therapy for vestibular migraine: clinical efficacy and neurobiochemical correlates - Scorecard - MDSpire

Combined biofeedback and vestibular rehabilitation therapy for vestibular migraine: clinical efficacy and neurobiochemical correlates

  • By

  • Tengteng Zhang

  • Ying Zhang

  • Jinghui Sun

  • Luting Lv

  • Hongwei Wang

  • He Zhang

  • Jie Li

  • Jiandong Wang

  • Zhidan Yu

  • Shuqin Wu

  • June 23, 2026

  • 0 min

Share

Clinical Scorecard: Integrating Biofeedback with Vestibular Rehabilitation for Managing Vestibular Migraine: Clinical Outcomes and Neurobiochemical Insights

At a Glance

CategoryDetail
ConditionVestibular Migraine
Key MechanismsInvolves dysfunction in sensory processing networks, neurotransmitter imbalance, and altered central vestibular processing.
Target PopulationPatients with vestibular migraine (VM)
Care SettingTertiary care center

Key Highlights

  • Combined therapy achieved a total effective rate of 94.59%.
  • Significant improvements in anxiety, depression, vertigo disability, and balance function were observed.
  • Neurobiochemical modulation included increased serotonin and GABA levels, and decreased CGRP and acetylcholine levels.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of VM should consider recurrent vertigo episodes and associated migraine symptoms.

Management

  • Non-pharmacological strategies, including vestibular rehabilitation and biofeedback, are recommended.

Monitoring & Follow-up

  • Monitor changes in psychological outcomes and vestibular function parameters.

Risks

  • Consider potential side effects of pharmacological treatments for patients who may not tolerate them.

Patient & Prescribing Data

148 patients with vestibular migraine enrolled in a prospective study.

Combined biofeedback and vestibular rehabilitation therapy showed superior efficacy compared to individual treatments.

Clinical Best Practices

  • Integrate biofeedback with vestibular rehabilitation for enhanced treatment outcomes.
  • Assess neurobiochemical markers to evaluate treatment efficacy.

Related Resources & Content

Original Source(s)

Related Content